Logo for Cerevel Therapeutics Holdings Inc

Cerevel Therapeutics Investor Relations Material

Latest events

Logo for Cerevel Therapeutics Holdings Inc

Q3 2023

Cerevel Therapeutics
Logo for Cerevel Therapeutics

Q4 2023

27 Feb, 2024
Logo for Cerevel Therapeutics

Q3 2023

1 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Cerevel Therapeutics Holdings Inc

Access all reports
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of various therapies for neuroscience diseases. Cerevel Therapeutics Holdings, Inc. operates as a clinical-stage biopharmaceutical company. The company focuses on developing therapies for neurology diseases, such as Alzheimer and Parkinson's disease. It develops therapeutics in the areas of intracerebral drug delivery system, biomarkers and imaging tools, anti-inflammatory therapeutics, anti-amyloid antibodies, central nervous toxicity and other drug candidates. The company was formerly known as Cerevel Therapeutics PLC.